Suvretta Capital Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.33 Billion
- Q1 2024
A detailed history of Suvretta Capital Management, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 3,763,888 shares of EYPT stock, worth $31.1 Million. This represents 3.33% of its overall portfolio holdings.
Number of Shares
3,763,888
Previous 4,056,847
7.22%
Holding current value
$31.1 Million
Previous $93.8 Million
17.02%
% of portfolio
3.33%
Previous 4.87%
Shares
13 transactions
Others Institutions Holding EYPT
# of Institutions
176Shares Held
53.9MCall Options Held
764KPut Options Held
1.57M-
Cormorant Asset Management, LP Boston, MA6.89MShares$56.9 Million8.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.76MShares$39.3 Million0.19% of portfolio
-
Franklin Resources Inc San Mateo, CA3.39MShares$28 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$23 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.47MShares$20.4 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $281M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...